Cargando…
EQ-5D Utilities in Chronic Spontaneous/Idiopathic Urticaria
OBJECTIVES: To obtain utility estimates suitable for use in economic models for chronic spontaneous (idiopathic) urticaria (CSU). METHODS: Patient-level data from three randomized clinical trials—ASTERIA I, ASTERIA II and GLACIAL—were analysed. Health states were derived from the Urticaria Activity...
Autores principales: | Hawe, Emma, McBride, Doreen, Balp, Maria-Magdalena, Tian, Haijun, Halliday, Anna, Stull, Donald E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4828466/ https://www.ncbi.nlm.nih.gov/pubmed/26792790 http://dx.doi.org/10.1007/s40273-015-0375-7 |
Ejemplares similares
-
Cost Utility of Omalizumab Compared with Standard of Care for the Treatment of Chronic Spontaneous Urticaria
por: Graham, Jonathan, et al.
Publicado: (2016) -
Assessing Changes in Chronic Spontaneous/Idiopathic Urticaria: Comparisons of Patient-Reported Outcomes Using Latent Growth Modeling
por: Stull, Donald E., et al.
Publicado: (2016) -
Improvement of sleep in patients with chronic idiopathic/spontaneous urticaria treated with omalizumab: results of three randomized, double-blind, placebo-controlled studies
por: Gimenéz-Arnau, Ana M., et al.
Publicado: (2016) -
Clinical Remission of Chronic Spontaneous Urticaria (CSU): A Targeted Literature Review
por: Balp, Maria-Magdalena, et al.
Publicado: (2021) -
Treatment Patterns, Healthcare Resource Utilization, and Spending Among Medicaid-Enrolled Children with Chronic Idiopathic/Spontaneous Urticaria in the United States
por: Williams, Paul V., et al.
Publicado: (2018)